T 1618/06 (Purification of citalopram/LUNDBECK) of 02.07.2009
- European Case Law Identifier
- ECLI:EP:BA:2009:T161806.20090702
- Date of decision
- 2 July 2009
- Case number
- T 1618/06
- Online on
- 28 July 2009
- Petition for review of
- -
- Application number
- 01909568.6
- IPC class
- C07D 307/87
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Crystalline base of citalopram
- Applicant name
- H. LUNDBECK A/S
- Opponent name
- neuraxpharm Arzneimittel GmbH & Co. KG
Stada-Arzneimittel Aktiengesellschaft
Alfred E. Tiefenbacher GmbH & Co.
biomo pharma GmbH
Egis Gyógyszergyár NYRT.
Merck dura GmbH
Niche Generics Limited
Merck N. V. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 87(1) 1973European Patent Convention Art 100(a) 1973European Patent Convention R 115(2)
- Keywords
- Priority (valid) - feature disclosed in the section describing the prior art is referred to in the remaining part of the description
Novelty (yes)
Inventive step (yes) - non obvious solution - Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the
order to maintain the patent based on the amended Main Request (claims 1-7) filed during the oral proceedings before the Board and after any necessary consequential amendment of the description.